国家医保局等两部门：持创新药进入基本医保药品目录和商业健康保险创新药品目录

Core Viewpoint - The National Healthcare Security Administration and other departments are enhancing the dynamic adjustment mechanism for the basic medical insurance drug list, allowing innovative drugs to be included in the insurance coverage under certain conditions [1] Group 1 - The basic medical insurance drug list will be regularly adjusted and optimized based on the capacity of the insurance fund, public medical needs, and clinical technological advancements [1] - Innovative drugs that meet specific criteria will be included in the basic medical insurance drug list while maintaining a focus on essential coverage [1] - In response to major public health events, there will be a consideration for temporarily including necessary innovative drugs in the insurance payment scope through discussions with relevant departments [1]